| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/29/2011 | US20110236397 Limited proteolysis of cd2ap and progression of renal disease |
| 09/29/2011 | US20110236360 Lactic acid bacterium having high oxalic acid decomposition ability |
| 09/29/2011 | US20110236353 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 09/29/2011 | US20110236352 PEGylation by the Dock and Lock (DNL) Technique |
| 09/29/2011 | US20110236346 Compositions and Methods for Treatment of Radiation Exposure |
| 09/29/2011 | CA2793153A1 Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias |
| 09/28/2011 | EP2368986A1 Promoter for introducing gene into lymphocyte or blood cell and application thereof |
| 09/28/2011 | EP2368983A2 Recombinant human factor IX and use thereof |
| 09/28/2011 | EP2368910A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 09/28/2011 | EP2368898A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 09/28/2011 | EP2368876A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 09/28/2011 | EP2368565A1 Enrichment of pre-beta high density lipoproteins |
| 09/28/2011 | EP2368558A1 Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates |
| 09/28/2011 | EP2367530A2 Solutions for volume therapy |
| 09/28/2011 | EP1237891B1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 09/28/2011 | EP1144613B1 Methods for making proteins containing free cysteine residues |
| 09/28/2011 | CN1615908B Absorbent for oral administration, and agent for treating or preventing renal or liver disease |
| 09/28/2011 | CN1346369B Method and compositions for the prevention and treatment of anamia |
| 09/28/2011 | CN102203096A Compounds that expand hematopoietic stem cells |
| 09/28/2011 | CN102202670A Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia |
| 09/28/2011 | CN102202657A Encapsulated functional fine particle composition capable of spraying and preparation method thereof |
| 09/28/2011 | CN102202519A Method for producing lipid |
| 09/28/2011 | CN102199615A cDNA sequence coding fibrinolysin, amino acid sequence and applications of sequences |
| 09/28/2011 | CN102199587A Functional mutant of human plasminogen, its preparation method and application |
| 09/28/2011 | CN102199584A Antithrombotic enzyme Eupolytinl from Eupolyphaga sinensis Walker and gene and application thereof |
| 09/28/2011 | CN102199163A 2-hydroxy tetrahydrothiophene derivative, preparation method thereof and application thereof in pharmacy |
| 09/28/2011 | CN102199150A Optical active oxazolidinone derivatives as well as preparation methods and application to preparing medicaments |
| 09/28/2011 | CN102199123A New crystal form and pharmaceutical application of fasudil |
| 09/28/2011 | CN102198222A Medicament for treating anaphylactoid purpura |
| 09/28/2011 | CN102198165A Method of preparing dogwood powder by adopting cell wall breaking technique |
| 09/28/2011 | CN102198148A Compound malic acid Ringer's solution and application thereof |
| 09/28/2011 | CN102198147A New preparation method for aspirin-containing compound preparation |
| 09/28/2011 | CN102198095A Epoprostenol fat emulsion and preparation method thereof |
| 09/28/2011 | CN102198094A Artificial tear containing polyacrylic acid and sodium hyaluronate and preparation method thereof |
| 09/28/2011 | CN101849988B Millettia extract and preparation method and application thereof |
| 09/28/2011 | CN101843649B Chinese medicament for treating colporrhagia and preparation method thereof |
| 09/28/2011 | CN101838323B Anti-platelet thrombolysin and preparation method thereof |
| 09/28/2011 | CN101745103B Normal-temperature preserved albumin preparation |
| 09/28/2011 | CN101744902B Medicament for treating burns, traumatic hemorrhage and preparation method thereof |
| 09/28/2011 | CN101491519B Bilobalide injector and preparation method thereof |
| 09/28/2011 | CN101340921B Extract for preventing and treating embolus disease |
| 09/28/2011 | CN101333531B CXCR4 antagonist recombination protein SDF-1 beta P2G, preparation method and application thereof |
| 09/28/2011 | CN101300252B Novel cycloalkane carboxamides as factor Xa inhibitors |
| 09/27/2011 | US8026273 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
| 09/27/2011 | US8026072 Method of identifying compounds that bind BAFF-R |
| 09/27/2011 | CA2506476C Method of treatment of myocardial infarction |
| 09/27/2011 | CA2475930C 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6 |
| 09/27/2011 | CA2440630C Metalloproteinase inhibitors |
| 09/27/2011 | CA2440042C Carboxamide derivatives as therapeutic agents |
| 09/27/2011 | CA2213331C Chemokine receptors 88-2b [ckr-3] and 88c and their antibodies |
| 09/22/2011 | WO2011115183A1 Novel monocyclic pyrimidine derivative |
| 09/22/2011 | WO2011115067A1 Method for improving dissolvability of anticoagulant |
| 09/22/2011 | WO2011115066A1 Crystal of diamine derivative and method of producing same |
| 09/22/2011 | WO2011115065A1 Cyclopropanecarboxylic acid derivative |
| 09/22/2011 | WO2011115064A1 Cycloalkyl-substituted imidazole derivative |
| 09/22/2011 | WO2011114916A1 Composition for prevention or treatment of anemia |
| 09/22/2011 | WO2011114160A1 Anagrelide derivatives (imidazo [2, 1-b] quinazolin - 2 - ones ) as pde iii inhibitors useful as antithrombotic agents |
| 09/22/2011 | WO2011113608A1 Esterified polysaccharide osmotic agents |
| 09/22/2011 | WO2011092720A3 Pharmaceutical composition of prasugrel and its pharmaceutically acceptable salts and process for their preparation |
| 09/22/2011 | US20110230559 Tranexamic Acid Formulations |
| 09/22/2011 | US20110230552 Use of dronedarone for the preparation of a medicament for the prevention of stroke or transient ischemic attack |
| 09/22/2011 | US20110230521 Pyrazole Compounds As CCR1 Antagonists |
| 09/22/2011 | US20110230477 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders |
| 09/22/2011 | US20110230451 Identification and use of compounds that affect the fidelity of eukaryotic translation initiation codon selection |
| 09/22/2011 | US20110229944 FAD4, FAD5, FAD5-2, AND FAD6, Novel Fatty Acid Desaturase Family Members and Uses Thereof |
| 09/22/2011 | US20110229573 Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form |
| 09/22/2011 | US20110229571 Pharmaceutical Compositions Comprising a Selective I1 Imidazoline Receptor Agonist and an Angiotensin II Receptor Blocker |
| 09/22/2011 | US20110229496 Method for regulating survival and memory of t helper 1 cells |
| 09/22/2011 | US20110229476 Monospecific and multispecific antibodies and method of use |
| 09/22/2011 | US20110229475 Novel compounds |
| 09/22/2011 | US20110229472 Peptides and Related Compounds Having Thrombopoietic Activity |
| 09/22/2011 | US20110229455 Stabilized liquid and lyophilized adamts13 formulations |
| 09/22/2011 | US20110229454 Use of Prourokinase and Variants Thereof in Facilitated Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction |
| 09/22/2011 | US20110229453 Blood coagulation factor inhibitors |
| 09/22/2011 | US20110229409 Linkable lewis x analogs |
| 09/22/2011 | DE102010012281A1 Pharmazeutische Zusammensetzungen enthaltend substituiertes 6-Deoxy-6-sulfanylcyclodextrin To pharmaceutical compositions containing substituted 6-deoxy-6-sulfanylcyclodextrin |
| 09/22/2011 | DE102010012199A1 Molekular geprägte Polymere für die Eliminierung von Metaboliten Molecularly imprinted polymers for the elimination of metabolites |
| 09/22/2011 | DE102010012183A1 Veresterte Polysaccharid-Osmotika Esterified polysaccharide osmotica |
| 09/22/2011 | DE102010012179A1 Vorrichtung für die Peritonealdialyse Apparatus for peritoneal dialysis |
| 09/22/2011 | CA2793525A1 Method for improving dissolution of anticoagulant agent |
| 09/22/2011 | CA2793523A1 Cyclopropanecarboxylic acid derivative |
| 09/22/2011 | CA2793413A1 Crystal form of edoxaban tosylate monohydrate and method of producing same |
| 09/22/2011 | CA2791505A1 Cycloalkyl-substituted imidazole derivative |
| 09/21/2011 | EP2366706A1 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 09/21/2011 | EP2366397A1 Intravascular indwelling catheter lock solution containing acetic acid and container containing the same |
| 09/21/2011 | EP2366389A1 Severe sepsis preventive therapeutic agent |
| 09/21/2011 | EP1436298B1 Himbacine analogues as thrombin receptor antagonists |
| 09/21/2011 | EP1399556B1 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 09/21/2011 | EP1200385B2 Process for the preparation of crystals of the sodium salt of pravastatin |
| 09/21/2011 | CN1718735B Production of polyglutamic acid using na bean bacillus solid fermentation and its product application |
| 09/21/2011 | CN102196733A Method for concentrating lipid |
| 09/21/2011 | CN102191305A Preparation method of hoof nail polypeptide through composite hydrolysis |
| 09/21/2011 | CN102190815A Chitosan derivative self-crosslinked antimicrobial hydrogel using oxidized konjak as crosslinking agent and preparation method thereof |
| 09/21/2011 | CN102190728A Novel humanized anti-CD20 monoclonal antibody |
| 09/21/2011 | CN102190644A Chiral 3-hydroxypyridin-4-one derivatives, synthesis and application thereof |
| 09/21/2011 | CN102190632A 2,4,5-trisubstituted selenazole compounds and preparation method, compositions and application thereof |
| 09/21/2011 | CN102190622A Water-soluble derivatives of edaravone, preparation method and application thereof |
| 09/21/2011 | CN102188708A Compositions comprising nebivolol |
| 09/21/2011 | CN102188705A Medicament composition containing bis cyclooctane derivatives |
| 09/21/2011 | CN102188693A Novel proteoglycan complex |